MedTrace Logo

CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer

NCT00154804 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-08-23

No results posted yet for this study

Summary

CCRT with twice weekly paclitaxel and cisplatin in patient with locally advanced esophageal cancer.

Conditions

  • Esophageal Cancer

Interventions

DRUG

Paclitaxel, Cisplatin,Surgery, CCRT

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chih-Hung Hsu, M.D.,Ph.D. · Department of Oncology, National Taiwan University Hospital

  • Ann-Lii Cheng, M.D.,Ph.D · Department of Oncology, National Taiwan University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Completion
2004-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00154804 on ClinicalTrials.gov